# A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults

> **NCT05109390** · PHASE1 · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 72 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Danicopan
- **DRUG:** Cyclosporine
- **DRUG:** Tacrolimus
- **DRUG:** Calcium Carbonate
- **DRUG:** Aluminum/Magnesium Hydroxide/Simethicone
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT05109390
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-27
- **Primary completion:** 2018-10-17
- **Final completion:** 2018-10-17
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2021-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05109390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05109390, "A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05109390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*